z-logo
open-access-imgOpen Access
Parenteral Ascorbic Acid in Allogeneic HCT Recipients Is Safe and Ameliorates the Cytokine Milieu and Endothelial Injury Following Myeloablative Conditioning
Author(s) -
Gary Simmons,
Roy Sabo,
Erika J. Martin,
Donald F. Brophy,
Maja Silobrčić Radić,
Bernard Fisher,
Ramesh Natarajan,
Dayanjan S. Wijesinghe,
Alexandra Gol-Chambers,
C. E. Hall,
May Aziz,
Kelly G. Hawks,
Ali Jafri,
Robyn J. Bernard,
Harold M. Chung,
William Clark,
John M. McCarty,
Catherine Roberts,
Alpha A. Fowler,
Amir A. Toor
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.667
Subject(s) - medicine , busulfan , ascorbic acid , fludarabine , gastroenterology , total body irradiation , sepsis , melphalan , cyclophosphamide , mucositis , bone marrow , transplantation , hematopoietic stem cell transplantation , surgery , toxicity , chemotherapy , chemistry , food science

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom